Ingrid Strusberg

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis

Paul Emery, Roy Fleischmann, Larry W. Moreland et al. · Arthritis & Rheumatism · 2009 · 393 citations · Full text

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo‐controlled trial

René Westhovens, David E. Yocum, John Han et al. · Arthritis & Rheumatism · 2006 · 311 citations

Pharmacotherapy, Inflammatory Arthritis, Inflammation +20

Influence of weather conditions on rheumatic pain.

Ingrid Strusberg, Raquel C Mendelberg, Héctor Alejandro Serra et al. · PubMed · 2002 · 144 citations

Double-blinded infliximab dose escalation in patients with rheumatoid arthritis

M. U Rahman, Ingrid Strusberg, Piet Geusens et al. · Annals of the Rheumatic Diseases · 2007 · 107 citations · Full text

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg et al. · Annals of the Rheumatic Diseases · 2011 · 73 citations · Full text